MariMed Inc.: MagicMed Industries to present at the Planet MicroCap Showcase: Virtual on April 22nd
MagicMed Industries Inc. (
MagicMed or the
Company ), a biotechnology company focused on creating novel psychedelic derivative molecules, today announced that Dr. Joseph Tucker, President and Chief Executive Officer, will be presenting a business and pipeline update at the LifeSciencesInvestorForum.com on April 22
nd, 2021 as follows:
LINK: https://www.webcaster4.com/Webcast/Page/2059/40839
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, and archived webcast will also me made available after the event.
MagicMed Industries to present at the Planet MicroCap Showcase: Virtual on April 22nd
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
MagicMed Industries to present at the Planet MicroCap Showcase: Virtual on April 22nd
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
Cognistx to Collaborate on AI Initiative to Improve the Development of Psychedelic Medicine for the Treatment of Mental Health Illnesses
Share Article
Cognistx and MagicMed Industries Inc. will develop PsyAI™, a tool designed to streamline pharmaceutical design in an effort to accelerate the modernization of psychedelic medicines.
Cognistx
“The convergence of AI and psychedelic medicine will result in a medical renaissance – all to benefit the treatment of mental health conditions,” said Cognistx CEO Sanjay Chopra. “It’s very exciting to be at the nexus of this convergence of medicine with AI technology.” PITTSBURGH (PRWEB) April 09, 2021 Cognistx (Cognistx.com), a tech firm that designs artificial intelligence (AI) business solutions, announces its partnership with MagicMed Industries Inc. (“MagicMed”), a Canadian biotech company, to develop a groundbreaking AI tool (“PsyAI™”) intended